Psoriatic Arthritis

Reactivation Rate of Hepatitis B in Inflammatory Arthritis Tx With DMARDs

Reactivation Rate of Hepatitis B in Inflammatory Arthritis Tx With DMARDs

By

HBV reactivation rates were lower among all chronic HBV infection patients on antiviral prophylaxis, regardless of whether they were receiving TNF inhibitors.

Real-World Data Validates Minimal Disease Activity Index in PsA

Real-World Data Validates Minimal Disease Activity Index in PsA

By

Overall improvements in rates of minimal disease activity are achieved in patients with PsA when they are treated with anti-tumor necrosis factor agents

No Association Between Opioid Intake and Patient Satisfaction After Ankle Fracture

No Association Between Opioid Intake and Patient Satisfaction After Ankle Fracture

By

To improve pain relief, surgeons should proactively address stress, distress, and ineffective coping strategies.

Positive Correlation Between Smoking Amount, Duration and Psoriasis

Positive Correlation Between Smoking Amount, Duration and Psoriasis

By

Smoking is associated with the risk of psoriasis.

Sonographic Enthesitis as a Potential Marker of Radiographic Damage Severity in PsA

Sonographic Enthesitis as a Potential Marker of Radiographic Damage Severity in PsA

By

The association between sonographic enthesitis and severity of radiographic features of peripheral and axial joint damage in psoriatic arthritis was examined in a cross-sectional study.

Noninvasive Test Monitors Hepatic Fibrosis in Psoriasis Patients Taking Methotrexate

Noninvasive Test Monitors Hepatic Fibrosis in Psoriasis Patients Taking Methotrexate

By

A noninvasive test can be used to help monitor for risk of worsening fibrosis in psoriasis patients who have elevated hepatic steatosis.

Minimal Transfer of Certolizumab Pegol to Mature Breast Milk

Minimal Transfer of Certolizumab Pegol to Mature Breast Milk

By

The first lactation study of its kind evaluated whether a biologic drug is transferred into mature breast milk

FDA Approval of Biosimilar Cyltezo for Multiple Indications

FDA Approval of Biosimilar Cyltezo for Multiple Indications

By

Cyltezo subcutaneous injection has been approved by the FDA.

Findings of Psoriatic Arthritis Treatment Trends

Findings of Psoriatic Arthritis Treatment Trends

By

Less than 40% of psoriatic arthritis patients were treated with a bDMARD.

No Association Between Postop Opioid Intake and Patient Satisfaction After Ankle Fracture

No Association Between Postop Opioid Intake and Patient Satisfaction After Ankle Fracture

By

To improve pain relief, surgeons should proactively address stress, distress, and ineffective coping strategies.

Ultrasound-Detected Synovitis Predicts Short-term PsA Disease Flare

Ultrasound-Detected Synovitis Predicts Short-term PsA Disease Flare

By

The ability of Power Doppler Ultrasound to predict short-term psoriatic arthritis disease flare was investigated in a new study.

Psoriatic Arthritis, Cardiovascular Health Improved With Etanercept Therapy

Psoriatic Arthritis, Cardiovascular Health Improved With Etanercept Therapy

By

The researchers noted that the small changes in lipid profile do not account for the cardiovascular benefits seen in patients taking etanercept.

Early Predictors of Poor Long-Term Treatment Response in Spondyloarthritis

Early Predictors of Poor Long-Term Treatment Response in Spondyloarthritis

By

Determining which patients are unlikely to respond to therapy early on may help reduce unnecessary treatment and contain costs.

Tofacitinib Found to Improve Nail Psoriasis

Tofacitinib Found to Improve Nail Psoriasis

There was improvement in nail psoriasis severity at 16 weeks compared with placebo that was maintained through 52 weeks.

Serum Amyloid A Levels May Act as Biomarker for Disease Activity in Psoriatic Arthritis

Serum Amyloid A Levels May Act as Biomarker for Disease Activity in Psoriatic Arthritis

By

Repeated serum amyloid A measurements could act as an additional marker for monitoring disease activity over time in patients with psoriatic arthritis.

No Negative Effect on Disease Activity Seen in Switching Patients to Biosimilar Infliximab From Originator Drug

No Negative Effect on Disease Activity Seen in Switching Patients to Biosimilar Infliximab From Originator Drug

By

Researchers found similar disease duration the 3 months before and after the switch to CT-P13 in patients.

Ixekizumab Benefits Patients With Treatment-Resistant Psoriatic Arthritis

Ixekizumab Benefits Patients With Treatment-Resistant Psoriatic Arthritis

By

Ixekizumab was found to benefit patients with psoriatic arthritis showing poor response to conventional treatment when administered over a 2- or 4-week period.

Risk for Endocrine Comorbidities Increased in Psoriatic Arthritis

Risk for Endocrine Comorbidities Increased in Psoriatic Arthritis

By

Researchers evaluated the prevalence of several endocrine disorders in patients with psoriatic arthritis.

GRAPPA-OMERACT: PsA Outcomes Measures Updated for Greater Inclusion of Patient Concerns

GRAPPA-OMERACT: PsA Outcomes Measures Updated for Greater Inclusion of Patient Concerns

By

The domains for outcome measurement in clinical trials of psoriatic arthritis were updated by the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis and endorsed by Outcome Measures in Rheumatology.

GRAPPA-OMERACT: Updated PsA Outcomes Measures Offer Greater Inclusion of Patient Concerns

GRAPPA-OMERACT: Updated PsA Outcomes Measures Offer Greater Inclusion of Patient Concerns

By

The domains for outcome measurement in clinical trials of psoriatic arthritis were updated by the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis and endorsed by Outcome Measures in Rheumatology.

Uveitis Risk Higher Among Patients With Psoriasis

Uveitis Risk Higher Among Patients With Psoriasis

By

Patients with severe psoriasis and those with mild psoriasis and concomitant psoriatic arthritis have an increased risk of uveitis.

First Line Biologic for Psoriasis Influenced By Certain Factors

First Line Biologic for Psoriasis Influenced By Certain Factors

By

Psoriatic arthritis, patient weight, registration country and more influence first-line biologic treatment selection for patients with psoriasis.

Biosimilar Confidence: Physician-Patient Communication Sets the Tone

Biosimilar Confidence: Physician-Patient Communication Sets the Tone

By

Jonathan Krant, MD, FACP, confronts the issues surrounding biosimilar substitution for biologic treatments.

Measuring Disease Activity in Psoriatic Arthritis

Measuring Disease Activity in Psoriatic Arthritis

By

There are many tools to evaluate disease activity in psoriatic arthritis, but there is no consensus on which one to use.

Women Have Lower Psoriasis Area and Severity Index Scores Than Men

Women Have Lower Psoriasis Area and Severity Index Scores Than Men

By

Women were found to have a lower median of scores in the Psoriasis Area and Severity Index than men.

Psoriatic Arthritis Development Predicted by Musculoskeletal Symptoms

Psoriatic Arthritis Development Predicted by Musculoskeletal Symptoms

By

Prospective cohort study of patients with psoriasis who were assessed annually to examine for development of clinical psoriatic arthritis.

High-dose Steroids Increase Serious Infection Risk in Pregnant Women With Inflammatory Conditions

High-dose Steroids Increase Serious Infection Risk in Pregnant Women With Inflammatory Conditions

By

An observational cohort study of 4961 women with completed pregnancies and a recorded diagnosis of systemic inflammatory conditions.

Minimal Amount of TNF Inhibitor Transfers to Breast Milk, Study Finds

Minimal Amount of TNF Inhibitor Transfers to Breast Milk, Study Finds

By

Study evaluated breast milk samples from 17 lactating mothers diagnosed with rheumatoid arthritis, Crohn's disease, psoriatic arthritis, and axial spondyloarthritis/ankylosing spondylitis.

Secukinumab Efficacy for Psoriasis Examined After Treatment Pause

Secukinumab Efficacy for Psoriasis Examined After Treatment Pause

By

Findings come from 2 trials; one compared secukinumab with placebo, whereas the other compared secukinumab with placebo and etanercept.

Arthritis and Incident Myocardial Infarction Risk

Arthritis and Incident Myocardial Infarction Risk

By

Research comes from meta-analysis of 25 population-based studies on 5 major forms of arthritis.

Sign Up for Free e-newsletters